268 related articles for article (PubMed ID: 9340472)
1. [Value of biguanide in therapy of diabetes mellitus].
Haupt E; Panten U
Med Klin (Munich); 1997 Aug; 92(8):472-9, 505. PubMed ID: 9340472
[TBL] [Abstract][Full Text] [Related]
2. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
3. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
Irsigler K; Kritz H; Regal H; Foltin E
Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
[TBL] [Abstract][Full Text] [Related]
4. Biguanides and NIDDM.
Bailey CJ
Diabetes Care; 1992 Jun; 15(6):755-72. PubMed ID: 1600835
[TBL] [Abstract][Full Text] [Related]
5. [Biguanides: reasons for withdrawal of drugs and remaining indications].
Bolzano K
Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
[TBL] [Abstract][Full Text] [Related]
6. Biguanide-associated lactic acidosis. Case report and review of the literature.
Gan SC; Barr J; Arieff AI; Pearl RG
Arch Intern Med; 1992 Nov; 152(11):2333-6. PubMed ID: 1444694
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic utility of biguanides in the treatment of NIDDM].
Fujimoto S
Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
[TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of metformin in type 2 diabetes mellitus.
Howlett HC; Bailey CJ
Drug Saf; 1999 Jun; 20(6):489-503. PubMed ID: 10392666
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
10. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.
Luft D; Schmülling RM; Eggstein M
Diabetologia; 1978 Feb; 14(2):75-87. PubMed ID: 344119
[TBL] [Abstract][Full Text] [Related]
11. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
12. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
14. Comparative tolerability profiles of oral antidiabetic agents.
Krentz AJ; Ferner RE; Bailey CJ
Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
[TBL] [Abstract][Full Text] [Related]
15. Role of metformin in treatment of diabetes mellitus.
Vigneri R; Goldfine ID
Diabetes Care; 1987; 10(1):118-22. PubMed ID: 3552509
[TBL] [Abstract][Full Text] [Related]
16. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
Bruneder H; Klein HJ
Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
[TBL] [Abstract][Full Text] [Related]
17. [Traditional contraindications to the use of metformin -- more harmful than beneficial?].
Holstein A; Egberts EH
Dtsch Med Wochenschr; 2006 Jan; 131(3):105-10. PubMed ID: 16418951
[TBL] [Abstract][Full Text] [Related]
18. Metformin: historical overview.
Bailey CJ
Diabetologia; 2017 Sep; 60(9):1566-1576. PubMed ID: 28776081
[TBL] [Abstract][Full Text] [Related]
19. Review of Biguanide (Metformin) Toxicity.
Wang GS; Hoyte C
J Intensive Care Med; 2019; 34(11-12):863-876. PubMed ID: 30126348
[TBL] [Abstract][Full Text] [Related]
20. Biguanide related lactic acidosis: incidence and risk factors.
Aguilar C; Reza A; García JE; Rull JA
Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
